Dr. Tolikas most recently served as CEO at Wyss Center for Bio & Neuroengineering in Switzerland, Before that, she spent nearly 10 years as an operations director at Cambridge, Mass.-based Harvard University, where she was an important part of the Wyss Center’s growth at the university, according to a March 15 news release.
At Dana-Farber, Dr. Tolikas will be tasked with leading the organization’s innovation strategy by forming strategic partnerships and identifying opportunities for technology improvement.
“Mary’s extensive experience in establishing and growing technology-based organizations in both industry and academia will serve her well in this role and will be instrumental as she grows our work in this important area,” Dana-Farber CEO Laurie Glimcher, MD, said in the release.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
